机译:新疗法对抗阉割前列腺癌初步管理的影响:澳大利亚多期面研究
Department of Medical OncologyMonash HealthMelbourne Victoria Australia;
Department of Medical OncologyPeter MacCallum Cancer CentreMelbourne Victoria Australia;
Department of Medical OncologyPeter MacCallum Cancer CentreMelbourne Victoria Australia;
Department of Medical OncologyWestern HealthMelbourne Victoria Australia;
Department of Medical OncologyPeter MacCallum Cancer CentreMelbourne Victoria Australia;
Division of Systems Biology and Personalised MedicineWalter and Eliza Hall Institute of Medical;
Department of Medical OncologyWestern HealthMelbourne Victoria Australia;
Department of Medical OncologyWestern HealthMelbourne Victoria Australia;
Department of Medical OncologyPeter MacCallum Cancer CentreMelbourne Victoria Australia;
Division of Systems Biology and Personalised MedicineWalter and Eliza Hall Institute of Medical;
Department of Medical OncologyPeter MacCallum Cancer CentreMelbourne Victoria Australia;
clinician preference; castration‐resistant prostate cancer; systemic treatment; secondary hormonal treatment; chemotherapy;
机译:新疗法对抗阉割前列腺癌初步管理的影响:澳大利亚多期面研究
机译:一项回顾性研究:在最初的雄激素剥夺治疗期间,前列腺特异性抗原的水平迅速下降是早期发展为去势抵抗性前列腺癌的危险因素
机译:手术去势有效地延迟了对雄激素剥夺治疗无效的去势抵抗性前列腺癌患者开始全身化疗的时间
机译:抗阉割前列腺癌的男性疗法测序
机译:改善肌横截面积,并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后,将物理静脉凝集维持
机译:一项回顾性研究:在初始雄激素剥夺治疗期间前列腺特异性抗原的水平迅速下降是早期发展为去势抵抗性前列腺癌的危险因素
机译:先前局部治疗对具有转移性阉割前列腺癌的男性整体生存的影响:共享平等接入区域癌症医院的结果